Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

Ítems similars

• Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease
  per: Sacre, Karim, et al.
  Publicat: (2005)
• Transient Mobilization of Human Immunodeficiency Virus (HIV)-Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 Infection
  per: Carcelain, Guislaine, et al.
  Publicat: (2001)
• Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)
  per: Guiguet, Marguerite, et al.
  Publicat: (2008)
• Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy
  per: Wirden, Marc, et al.
  Publicat: (2004)
• Cell-Mediated Immune Responses to COVID-19 Infection
  per: Guihot, Amélie, et al.
  Publicat: (2020)